pcu manual health prevention 1

8/12/2019 PCU Manual Health Prevention 1

1/218


2/218

9,750

2554


3/218


4/218

2 17 1. 1) 2) .. 3) .. 4).. 5) 6)

7) .. 8) .. 9) 2.1) 2) 3) .. 4) .. 5) 6)

.. 7) : 8)


5/218

- - - - -

.........

1.........................................................

2.

......................

2.1...............................

2.2...............

2.3

...........................................

2.3.1

..................

2.3.2

......................................

2.3.3

.......................

1

3

9

9

11

13

13

15

16

1.


6/218

2.3.4

...........................

2.3.5

/...2.3.6 .......

2.3.7

..........

............1.........

1.1

.................................................

1.2

..................................................

1.3:

..........................

1.4

17

1920

21

23

25

25

33

35

39

2.


7/218

2........

2.1

.....................................

2.2

.................

2.3(Risk assessment)

...........................................2.4

......................

2.5

..............................

2.6

........................................

43

43

45

46

49

50

53


8/218

......................................................

1.....................................2..................

3.

.................................

4.

............................................4.1

..........................................

4.2

..........................................

4.3

.................

4.4..

55

5859

61

66

66

68

71

73

3.


9/218

4.5:

.......

4.62552

..

...................

4.7Best Practice

2552

...............

1./

.........................................

2.

..................................

75

79

82

85

87

91

4.


10/218

3.

.......................

.

1.

.......................................

2...........

3..............................................

1.....

2./

3...........

93

109

111

113

117

119

121

123

128

5.

6.


11/218

...........................................................

................................................................

....

............................

..............

..................................

.. 2534-2552.............

...................................................

139

145

147

171

177

183

191

199

-


12/218

- - - - -

......................................

...................................................

.......................

..........................................................

....................

...........................

().....................................

2009.............................................

..............................

28

3440

41

44

54

95

97

98

101

1

23

4

5

6

7

8

9

10


13/218

.......................................................

.........................................................

...................................

/................................

103

106

108

115

11

12

13

14


14/218


15/218

1

1-


16/218

2


17/218

3

1.

1


18/218

4

2009 ( 1 1)


19/218

5

/ 4 /

85

500,000 1 5


20/218

6

(AFP) (Elimination)


21/218


22/218

8

10


23/218

9

2.

..

2.1

3 (Epidemiological triad) ( ) ()(Host) (Agent) (Environment) 1

1


24/218

10

()

(Host)

( ) ( )

(Agent)

() ( )

(2009)

(Environment)


25/218

11

2.2

3

(1) (Primary prevention)

() (


26/218

12

) ( ) () (

)(2) (Secondary prevention)

( Early detection andprompt intervention) ( ) (

)(3) (Tertiary prevention)


27/218

13

() (

)

2.32.3.1

o

(Isolation)


28/218

14

(Quarantine) ()

()

(

)

o

ultraviolet

o

(Chemoprophylaxis)

Isoniazid


29/218

15

o

o

2.3.2

o

o

( ) ( ) ( )


30/218

16

o

(yellow fever) (Chemoprophylaxis)

()

o

o

2.3.3

(1)

(2)


31/218

17

(3)

2.3.4 (1)

(2)


32/218

18

1-3

(3)

(4)

(5)

(.)


33/218

19

2.3.5 /

/(1)

/

(2)(3)

(4)//

(5)


34/218

20

/

2.3.6


35/218

21

(1)(Populationapproach) ""

(2)(High riskapproach)

2.3.7

(1)


36/218

22

(2)

5 .

(3)

(4)

(5)


37/218

23

2 ..


38/218

24


39/218


40/218

26

.. 2

(1)

(2) 2


41/218


42/218

28

1


43/218

29


44/218

30


45/218

31


46/218

32


47/218

33

..

- ? ? (

)

-

-

-

1.2 ..

..


48/218

34

..

..

2

2 ..


49/218

35

1.3 :

(1) .. 2


50/218

36

2

..

.


51/218

37

(2).

(Cold chain system)

(Adverse Event Following Immunization:AEFI)

..

1) (OPV)

-150C -25 0C 2) BCG, Measles

MMR+20C +80C

3) HB, DTP, DTP-HB, dT, JE,Influenza, Rabies TT +20C +80C

()


52/218

38

4) +20C +80C()

..

1) .. (DomesticRefrigerator) 5

(.) 3

2) 24 (ice-packs)

4

3)

..


53/218


54/218

40

5 43


55/218

41

4

5(5As)

1) Ask

2)Advise


56/218

42

3)Assess 5 Rs

o Relevance

o Risks

o Rewards

o Roadblocks

o Repetition

4)Assist

5) Arrange (the follow up)


57/218

43

2.1 SRRT

2.

http://www.boe.moph.go.th/files/report/20110126_69733020.pdf ..SRRT SRRT

(1)(2)

(3)(4)(5)(6)


58/218

44

5

5

:..


59/218

45

1 ..

2.2

(Watch Dog)

1)

2) 3)

.


60/218


61/218

47

(1)

(2) (3)

- .01


62/218

48

- 7 1 Reactive paper

( 2554)

..


63/218

49

2.4

..

5

35

(1)35


64/218

50

(2)

(3)

(4)"

"

(5)(6)

(7)

2.5..

/


65/218

51

4

(1)

(2)

..

(3)(Demand)

-

/


66/218

52

-

-

(Supply)

-

- /

-


67/218

53

(4) ..

2.6

..

6


68/218

54

6


69/218

55

3


70/218

56


71/218

57

3

..

.. ..

..


72/218

58

: (2553 : 227)

1.

"" (Network)


73/218

59

2.

(1)(Exchange Theory)

(2) (Synergy)


74/218

60

(3) (Division of labour) -

(4)

.

.

(1)

(2)

(3)


75/218

61

3.

.

.. (1)

. . ..


76/218

62

(2) ..

..

/


77/218

63

(3)

(4)

(5)

(6)


78/218

64

(7)

(8)

(9)

(..)

(1)


79/218


80/218

66

(5) NGO

(6) (7)

..

4.

.

. 4.1


81/218

67

(1)

1)

2)

13

3)

4)

5)

6)

7)


82/218


83/218

69

35 2553 10 9 2

1)

2)

3

/

3) , , , ,


84/218

70

4)

5)

6)

7)

8) 1 1

50-60


85/218


86/218

72

5)

6)

7)

8) /

(

)

9) , ,

10)

11) ,


87/218

73

12)

13)1)

2) coaching

3)

4)

"... ..."

4.4.. /

.. /


88/218

74

.. .

..

2550 - 2553 12 .

""

.


89/218

75

82

1 17

4.5

:

1) (.)

(.) () ()


90/218


91/218

77

/() .

4)

20

(

.)

5) 10 10

6)

() 10


92/218

78

7) 6 ( 75.0)

8)

10

.

1)

2)

3)


93/218

79

4) .

5)

4.6 2552 ..

..

487 .. 2551235 (48.25)58.7.. 2550-2552

70 .


94/218

80

1)

- .

- -

-

2) - .

-

-

- -

3

7 .. 10


95/218

81

.. 2552

1,153 2552 (24.98%) 2551(48.25%) 2552 2551


96/218

82

..

4.7 Best Practice 2552


97/218

83


98/218

84

: 11 , 2552

:http://www.moph.go.th

http://www.ddc.moph.go.thhttp://www.thaivbd.org.http:dhf.ddc.moph.go.th


99/218

85

4


100/218

86


101/218

87

4

1.

/

(1)

6 ()


102/218

88

5

1)

2)


103/218

89

3)

4)

5)

6)


104/218

90

(2)

() ()

(3)

3

1) "(Informing)"


105/218

91

2) " (Persuading)"

3) "(Consulting)" ()

2.

(1)

(2)

(3)(message) (channel)

- ()- - ,


106/218

92

- Hotline- - - MSN messenger

(4)

-

- - /- -

- (5)

- (Population at risk)- - - - -


107/218

93

3.

..


108/218

94

1)

2) 3) /4) 5) 6)

7)


109/218

95

7


110/218

96


111/218


112/218

98

9

2009


113/218


114/218

100


115/218

101

10


116/218


117/218

103

11


118/218

104


119/218

105


120/218

106

12


121/218

107


122/218

108

13


123/218

109

5 ..


124/218


125/218

111

5

..

/

1.

(1)(Monitoring)

/

/


126/218

112

(2)/

/ / /

1)

2) 3)

4)


127/218

113

2.

/

(Monitoring)

1) PERT CPM

2)

3)


128/218

114

4)

5)

6)

PERT CPM /

/


129/218


130/218

116

3

1) (Policy Decision)

2) (Administration Decision)

3) (Operation Decision)


131/218

117

3.

-

506


132/218


133/218

119

6


134/218


135/218

121

6

(..) : Surveillance and Rapid Response Team(SRRT)


136/218

122


137/218

123

/

(Essential Requirements)

/


138/218

124

1.1.1 -

2.2.1

-

Universal precaution


139/218

125

2.2-

-

3.3.1

-

-

Positive/Negative control

/- -


140/218

126

3.2 - -

4.

4.1

4.2 -

4.3

-


141/218

127

5.5.15.2

6.6.1

Positive/Negative control

6.2

6.3

7.7.1

8.8.1


142/218

128

8.2 8.3

1. : DMSCMalaria P.f./Plan Rapid Test

Plasmodium falciparum (P.f.),Plasmodium vivax(P.v.), Plasmodium malariae(P.m.)

Plasmodium ovale(P.o.)


143/218

129

DMSC Malaria P.f./PlanRapid Test

Plasmodium falciparum

Non-P.falciparum (Whole blood)Immunochromatography

: 2 Pan, C

Non - Plasmodium falciparumPlasmodium vivax(P.v.), Plasmodium malariae(P.m.) Plasmodium ovale(P.o.)

3 P.f., Pan, C Plasmodium falciparummix infection


144/218

130

: 1 C

2.: Lepto Latex Test kit

Latex

1.Latex Slide 1 (50)2.1 (50) Latex3.Latex

4.5-10


145/218

131

Latex 5-10

: :

3.: Leptospira Ab

Leptospira Ab IgGImmunochromatography"T"


146/218

132

IgG "T" IgG

"C"

1.

30

2. 10

(Dropper) 3-4


147/218

133

3.sample running buffer 6

4.15

2 "C""T"

1 "C"

1 "T"


148/218

134

1.

2.

3.Microscopic Agglutination test

4.

5.

4.: Leptospira IgMLeptospira IgM

IgM Immunochromatography"T"

IgM


149/218

135

"T" IgM "C"

1. 30

2. 5

(Dropper) 1-2


150/218

136

3.sample running buffer 6

4.15

2 "C""T"

1 "C"

1 "T"


151/218

137

1.

2.

3.Microscopic Agglutination test

4.

5.


152/218

138


153/218

139


154/218

140


155/218

141

. (2552). . : .

(2553).

( . .) . 2.: .

(2553). .

. (2543). .

2. : .

. ..2552 , 2552.

. "" . , 2551


156/218

142

.(2542). /.: . .(2553).

. . :

. . (2551). .

2. : Graphic PrintingPrepress Systems (Thailand) Co., Ltd.

, , ,

, , . . , 2546.

.(2538). .: .

. (2544). : .: .. (2553).

.:.


157/218

143

. (2553). (H1N1)2009.: .

Bartle, Phil. (2008).The Nature of Monitoring and Evaluation

:Definition and Purpose. Retrieved july13, 2008, from

http://www.scn.org/cmp/modules/mon-wht.htm.


158/218

144


159/218

145


160/218

146


161/218

147

-


162/218

148


163/218

149

-

(Influenza)

:

:

3 - 7

: 1 - 3


164/218

150

5

7 - 10 :

:

2


165/218

151

:

- -

-

-


166/218

152

-

-

-

(AvianInf

luenza)

:


167/218

153

:3 - 7

70

:

2

:


168/218

154

:1.

2.


169/218

155

3.

4.

()

:1.


170/218


171/218

157

(Hand,Foo

tand

MouthDisease)

2.

3.

4.

(Enterovirus)

5


172/218

158

:

1

:3 - 6 1 - 2

( ) 7 - 10

:


173/218

159

71 (Enterovirus 71)

:

(

) ()

:"

5 - 7


174/218

160

"

- (5 - 7 )

-

(20

1

)

-

-

1.3


175/218

161

2.

3.4.5.6.

7.


176/218

162

()

(1)

(2)

(3)

2

(4)

(5)


177/218

163

(AIDS Acquired

Immuno Deficiency Syndrome)

(HIV HumanImmunodeficiency Virus)

/

/1./

84

2./


178/218

164

/

3./

/2 1.

6

2. 7 2

2.1

2.2


179/218

165

//

1./ /

2.

3./

4. /


180/218

166

/

1.///

/

2.

/

/ /

3./ /


181/218

167

//

6 /

6 2

1./2./

6

/ (Window Period)

//


182/218

168

/6-10 / /

/ /

-

-


183/218


184/218

170

- Hepatitis B virus infection ( ) HIV/AIDS (Anogenital Herpes) (Trichomoniasis) (genitalmolluscum contagiosum) (Anogenital warts) (Scabies) (Pediculosis

pubis) (Candida vaginitis/balanitis)-

1.2.

3.4.

5.6.7.

4-6


185/218

171

-


186/218

172


187/218

173


188/218


189/218

175


190/218

176


191/218

177


192/218

178


193/218

179


194/218

180

1

1 1


195/218

181

- (dT)


196/218

182

1.

1.1

1.2

30 1.3

1-2

1.4


197/218

183


198/218

184


199/218

185

1

(1)

( ),,,(


200/218

186

), () ()

(2)

(3)/

... () , /( ), (),/ (),

/

,

(), , () ,

()

-

- /

-


201/218


202/218

188

3

(1)

-

/

-

-

-


203/218

189

- ()

-

- -

(2)


204/218

190

4 (1)(2)(3)(

)

()


205/218

191

.. 2534 - 2552


206/218

192


207/218

193

(1) 18 ( 2534 - 2552) 15 32.00 2534 20.70 2552 2

4

.

. 2552

.. 2550 5

1 3 " " 1 1 " "


208/218

194

115 .. 2552

.. 2552, 2553.

.. 2552 4 15 (-)25 - 40


209/218

195

60 (2)2 15.. 2552


210/218

196

2553 - 2557


211/218

197

. (2551). . 1. : .

(2553) ..2534 - 2552..

. (2550)..: .

. (2550). .9. :

.. (2553).

.: .


212/218

198

. (2551). .: .

. (2552). .: .

. (2551). .:. downloadhttp://thaigcd.ddc.moph.go.th/mediapublics.

http : // www.aidsthai.org http : // www.stisthai.org


213/218

199


214/218

200


215/218

201

.

. . .

.


216/218

202

. . . .

. . . . .

.

.


217/218

203

.


218/218

pcu manual health prevention 1

Documents